UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000032281
Receipt No. R000036812
Scientific Title Multi-center randomized controlled blind study of LC-4308 in Distal Radius Fracture patients treated with Volar Locking Plate scheduled to be removed
Date of disclosure of the study information 2018/04/17
Last modified on 2019/07/31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Multi-center randomized controlled blind study of LC-4308 in Distal Radius Fracture patients treated with Volar Locking Plate scheduled to be removed
Acronym Multi-center randomized controlled blind study of LC-4308
Scientific Title Multi-center randomized controlled blind study of LC-4308 in Distal Radius Fracture patients treated with Volar Locking Plate scheduled to be removed
Scientific Title:Acronym Multi-center randomized controlled blind study of LC-4308
Region
Japan

Condition
Condition Distal Radius Fracture patients treated with Volar Locking Plate scheduled to be removed
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate Safety and Efficacy of LC-4308 compared with Standard of care group for Distal Radius Fracture patients treated with Volar Locking Plate scheduled to be removed
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Adhesion at locking plate removal
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 LC-4308 (Adhesion Barrier System)
Interventions/Control_2 Standard of care
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1)Patients provided written informed consent
(2)Patients aged 20 years or older at the time of informed consent
(3)Patients who are diagnosed A2, A3, C1 or C2 by AO classification
(4)Patients who are able to keep splint for 1 week
(5)Patients who are scheduled to be removed locking plate
(6)Patients who are able to be tested according to the plan
(7)Patients who have surgery within 2 weeks after injury
Key exclusion criteria (1)Patients with an open fracture in the target site
(2)Patients complicated by other site fractures which may influence the evaluation of end points
(3)Patients with the possibility of the rupture of tendon, main nerve, or blood vessels in the target site
(4)Patients with the possibility of the combination of Artificial bones
(5)Patients with the possibility of the placement of the locking plate beyond the watershed line
(6)Patients unable to follow the instruction of rehabilitation
(7)Patients who have limited range of motion of either one or both thumbs
(8)Patients with high risk of fracture from the continuous treatment of oral steroids
(9)Patients with serious Cardiovascular diseases, Liver diseases, Respiratory diseases, Malignancy or Immunodeficiency at registration
(10)Patients with a history of severe drug allergies
(11)Patients with a history of Biodegradable plastic allergies
(12)Uncontrollable Diabetes mellitus
(13)Patients with pregnancy or possible pregnancy, patients who are breast-feeding, and patients who cannot prevent pregnancy properly until locking plate removal after informed consent
(14)Patients with Rheumatoid arthritis
(15)Patients who are continuing to undergo or have not yet finished their tests or other clinical studies under informed consent
(16)Others, patients who are judged as inadequately by principal investigator or sub-investigator
Target sample size 80

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kazuhiko Matsushita
Organization Kawasaki Municipal Tama Hospital
Division name Orthopedics
Zip code
Address 1-30-37 Shukugawara, Tama-ku, Kawasaki-shi, Kanagawa-ken
TEL 044-933-8111
Email k2matsu@marianna-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Shinji Namoto
Organization JMS CO.,LTD.
Division name Clinical Research Section Regulatory Affairs and Quality Assurance Division
Zip code
Address 12-17 Kako-machi, Naka-ku, Hiroshima-shi, Hiroshima-ken
TEL 082-243-6033
Homepage URL
Email s-namoto@jms.cc

Sponsor
Institute JMS CO.,LTD.
Institute
Department

Funding Source
Organization JMS CO.,LTD.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 04 Month 17 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 08 Month 31 Day
Date of IRB
2017 Year 11 Month 30 Day
Anticipated trial start date
2017 Year 12 Month 08 Day
Last follow-up date
2018 Year 12 Month 25 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2018 Year 04 Month 17 Day
Last modified on
2019 Year 07 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036812

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.